JMJD1C anticorps (AA 2019-2051)
Aperçu rapide pour JMJD1C anticorps (AA 2019-2051) (ABIN6242415)
Antigène
Voir toutes JMJD1C AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- AA 2019-2051
-
Purification
- This antibody is purified through a protein A column, followed by peptide affinity purification.
-
Immunogène
- This JMJD1C antibody is generated from a rabbit immunized with a KLH conjugated synthetic peptide between 2019-2051 amino acids from human JMJD1C.
-
Isotype
- Ig Fraction
-
-
-
-
Indications d'application
- WB: 1:1000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Date de péremption
- 6 months
-
-
- JMJD1C (Jumonji Domain Containing 1C (JMJD1C))
-
Autre désignation
- JMJD1C
-
Sujet
- Probable histone demethylase that specifically demethylates 'Lys-9' of histone H3, thereby playing a central role in histone code. Demethylation of Lys residue generates formaldehyde and succinate. May be involved in hormone-dependent transcriptional activation, by participating in recruitment to androgen-receptor target genes (By similarity).
-
Poids moléculaire
- 284525
-
UniProt
- Q15652
-
Pathways
- Nuclear Hormone Receptor Binding
Antigène
-